Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 May 2006 07:00 AM
RNS
Blocklisting Interim Review
16 May 2006 08:51 AM
RNS
Director/PDMR Shareholding
12 May 2006 07:00 AM
RNS
Agreement with FDA
04 May 2006 11:53 AM
RNS
Annual General Meeting 06
02 May 2006 07:01 AM
RNS
RETINOSTAT
20 Apr 2006 05:38 PM
RNS
Holding(s) in Company
11 Apr 2006 04:26 PM
RNS
Annual Report and Accounts
11 Apr 2006 08:21 AM
RNS
Annual Information Update
06 Apr 2006 01:23 PM
RNS
Holding(s) in Company
30 Mar 2006 07:01 AM
RNS
Clinical Trial Results
24 Mar 2006 12:40 PM
RNS
Holding(s) in Company
23 Mar 2006 11:03 AM
RNS
Director/PDMR Shareholding
16 Mar 2006 04:04 PM
RNS
Director/PDMR Shareholding
14 Mar 2006 07:00 AM
RNS
Preliminary Results
10 Mar 2006 07:00 AM
RNS
VIRxSYS Corporation Licence
23 Feb 2006 07:00 AM
RNS
Notice of Results
03 Feb 2006 09:48 AM
RNS
Board Appointment
26 Jan 2006 09:46 AM
RNS
Holding(s) in Company
24 Jan 2006 08:44 AM
RNS
Holding(s) in Company
18 Jan 2006 04:13 PM
RNS
Viragen Milestone
04 Jan 2006 10:12 AM
RNS
Holding(s) in Company
20 Dec 2005 04:42 PM
RNS
Holding(s) in Company
19 Dec 2005 05:10 PM
RNS
Holding in Company Correction
19 Dec 2005 04:55 PM
RNS
Holding(s) in Company
19 Dec 2005 11:07 AM
RNS
Holding(s) in Company
16 Dec 2005 01:45 PM
RNS
Director/PDMR S/hldg-Amend
16 Dec 2005 08:23 AM
RNS
Director/PDMR Shareholding
15 Dec 2005 09:00 AM
RNS
Director/PDMR Shareholding
12 Dec 2005 12:34 PM
RNS
Holding(s) in Company
12 Dec 2005 11:24 AM
RNS
Result of EGM
09 Dec 2005 11:43 AM
RNS
Holding(s) in Company
08 Dec 2005 03:31 PM
RNS
Holding(s) in Company
24 Nov 2005 11:37 AM
RNS
Holding(s) in Company
22 Nov 2005 04:12 PM
RNS
Blocklisting Interim Review
22 Nov 2005 12:17 PM
RNS
Holding(s) in Company
22 Nov 2005 07:00 AM
RNS
TroVax Notice of Allowance
17 Nov 2005 09:35 AM
RNS
Holding(s) in Company
16 Nov 2005 04:20 PM
RNS
Publication of Prospectus
16 Nov 2005 07:01 AM
RNS
Phase II trial with TroVax
16 Nov 2005 07:01 AM
RNS
Placing and Open Offer
15 Nov 2005 11:54 AM
RNS
Holding(s) in Company
02 Nov 2005 02:22 PM
RNS
Trovax & Proposed Fundraising
24 Oct 2005 01:49 PM
RNS
Trovax Clarification
24 Oct 2005 07:00 AM
RNS
Licence Agreement
20 Oct 2005 07:00 AM
RNS
Agreement with Sigma-Aldrich
19 Oct 2005 07:00 AM
RNS
Wyeth Preclinical Data
18 Oct 2005 11:30 AM
RNS
Additional Phase II Data
17 Oct 2005 07:00 AM
RNS
Final Phase II Results
06 Oct 2005 07:00 AM
RNS
Prelim Phase II Results
03 Oct 2005 01:54 PM
RNS
Change of Adviser

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100